nach oben

Virchows Archiv

Erschienen in:

01.01.2007 | Recommendation

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma

verfasst von: Jeremy R. Jass, Michael J. O’Brien, Robert H. Riddell, Dale C. Snover

Erschienen in: Virchows Archiv | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Excerpt

The reporting of colorectal cancer is facilitated by the provision of a checklist giving the features required for good patient care. However, the practicalities of applying such a checklist may not be straightforward. Familiar examples include finding the prescribed number of lymph nodes, distinguishing mesenteric tumor deposits from replaced lymph nodes, and deciding if a cluster of malignant cells in a lymph node sinus counts as a metastasis. Checklists have traditionally focused on prognostic factors and particularly tumor stage. It is becoming increasingly clear that additional factors, whether morphological or molecular, will be needed for future clinical management. It is also evident that prognosis is strongly influenced by surgical technique, most notably by the introduction of total mesorectal excision in the case of rectal cancer. …

AJCC cancer staging manual (2002). Lipincott-Raven, Philadelphia

Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA (2005) Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst 97:219–225PubMed

Bell SW, Mourra N, Flejou JF, Parc R, Tiret E (2005) Ex vivo sentinel lymph node mapping in colorectal cancer. Dis Colon Rectum 48:74–79PubMedCrossRef

Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712PubMedCrossRef

Cserni G (2002) Nodal staging of colorectal carcinomas and sentinel nodes. J Clin Pathol 56:327–335CrossRef

Doekhie FS, Peeters KCMJ, Kuppen PJK, Mesker WE, Tanke HJ, Morreau H, van de Velde CJH, Tollenaar RA (2005) The feasibility and reliability of sentinel node mapping in colorectal cancer. Eur J Surg Oncol 31:854–862PubMedCrossRef

Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato NEM, Fornasarig M, Boiocchi M (1999) High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 154:1805–1813PubMed

Fisher ER, Colangelo L, Wieand S, Fisher B, Wolmark N (2003) Lack of influence of cytokeratin-positive mini micrometastases in “negative node” patients with colorectal cancer: Findings from the National Surgical Adjuvant Breast and Bowel Projects protocols R-01 and C-01. Dis Colon Rectum 46:1021–1026PubMedCrossRef

Goldstein NS (2002) Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179–189PubMedCrossRef

10.

Goldstein NS, Turner JR (2000) Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas. Markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 88:2228–2238PubMedCrossRef

11.

Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (2005) Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with high level microsatellite instability. Arch Pathol Lab Med 129:1390–1397PubMed

12.

Greenson JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselvich I, Resnick MB, Trougouboff P, Tomsho LD, Kim E, low M et al (2003) Phenotype of microsatellite unstable colorectal carcinomas. Am J Surg Pathol 27:563–570PubMedCrossRef

13.

Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EWJ (1994) Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMedCrossRef

14.

Hamilton SR, Aaltonen LA (2000) World Health Organization classification of tumours. Pathology and genetics. IARC, Lyon

15.

Hase K, Shatney C, Johnson D, Trollope M, Vierra M (1993) Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum 36:627–635PubMedCrossRef

16.

Hori H, Fujimori T, Fujii S, Ichikawa K, Ohkura Y, Tomita S, Ono Y, Imura J, Kuroda Y (2005) Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma. Dis Colon Rectum 48:938–945PubMedCrossRef

17.

Howarth SM, Morgan JM, Williams GT (2004) The new (6th edition) TNM classification of colorectal cancer—a stage too far. Gut 53:A81

18.

Jass JR (2005) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2:398–405PubMedCrossRef

19.

Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, Radojkovic M, Restall AP, Stables SR, Zwi LJ (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543–548PubMedCrossRef

20.

Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMN, Todd IP (1986) The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 10:437–459PubMed

21.

Jass JR, Do K-A, Simms LA, Iino H, Wynter C, Pillay SP, Searle J, Radford-Smith G, Young J, Leggett B (1998) Morphology of sporadic colorectal cancer with DNA replication errors. Gut 42:673–679PubMedCrossRef

22.

Jass JR, Love SB (1989) Prognostic value of direct spread in Dukes’ C cases of rectal cancer. Dis Colon Rectum 32:477–480PubMedCrossRef

23.

Jass JR, Love SB, Northover JMA (1987) A new prognostic classification of rectal cancer. Lancet 1:1303–1306PubMedCrossRef

24.

Jass JR, Morson BC (1987) Reporting colorectal cancer. J Clin Pathol 40:1016–1023PubMed

25.

Kazama S, Watanabe T, Ajioka Y, Kanazawa H, Nagawa H (2006) Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 94:293–298PubMedCrossRef

26.

Merkel S, Mansmann U, Siassi M, Papadopoulos T, Hohenberger W, Hermanek P (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorect Dis 16:298–304CrossRef

27.

Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63:539–543PubMedCrossRef

28.

Nagtegaal ID, Marijnen CAM, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJH, van Krieken JHJM (2002) Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 197:20–27PubMedCrossRef

29.

Nagtegaal ID, Marijnen CAM, Kranenbarg EK, van de Velde CJH, van Krieken JHJM (2002) Circumferential margin involvement is still important predictor of local recurrence in rectal carcinoma. Not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357PubMedCrossRef

30.

Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734PubMedCrossRef

31.

Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45:200–206PubMedCrossRef

32.

Newland RC, Chapuis PH, Smyth EJ (1987) The prognostic value of substaging colorectal carcinoma. A prospective study of 1,117 cases with standardized pathology. Cancer 60:852–857PubMedCrossRef

33.

Newland RC, Dent OF, Chapuis PH, Bokey L (1995) Survival after curative resection of lymph node negative colorectal carcinoma: a prospective study of 910 patients. Cancer 76:564–571PubMedCrossRef

34.

O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96:1420–1425PubMedCrossRef

35.

Petersen VC, Baxter KJ, Love SB, Shepherd NA (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes’ B colon cancer. Gut 51:65–69PubMedCrossRef

36.

Quirke P (2003) Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 4:695–702PubMedCrossRef

37.

Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999PubMedCrossRef

38.

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma V-M (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318–324PubMedCrossRef

39.

Ryan R, Gibbons D, Hyland JMP, Treanor D, White A, Mulcahy HE, O’Donoghue DP, Moriarty M, Fennely D, Sheahan K (2005) Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 47:141–146PubMedCrossRef

40.

Saha S, Dan AG, Viehl CT, Zuber M, Wiese D (2005) Sentinel lymph node mapping in colon and rectal cancer: its impact on staging, limitations, and pitfalls. Cancer Treat Res 127:105–122PubMedCrossRef

41.

Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G, Roncoroni L (2005) Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 41:272–279PubMedCrossRef

42.

Shepherd NA, Baxter KJ, Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48:849–855PubMed

43.

Shepherd NA, Baxter KR, Love SB (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102PubMedCrossRef

44.

Shinto E, Mochizuki H, Ueno H, Matsubara O, Jass JR (2005) A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology 47:25–31PubMedCrossRef

45.

Smyrk TC, Watson P, Kaul K, Lynch HT (2001) Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer. Cancer 91:2417–2422PubMedCrossRef

46.

Sobin LH, Wittekind C (1997) TNM Classification of malignant tumours. Wiley-Liss, New York

47.

Sobin LH, Wittekind C (2002) TNM Classification of malignant tumours. Wiley-Liss, New York

48.

Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ, Morson BC (1981) Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 5:141–163PubMed

49.

Talbot IC, Ritchie S, Leighton MH, Hughes AO, Busey HJ, Morson BC (1981) Spread of rectal cancer within veins. Histologic features and clinical significance. Histopathology 5:141–163PubMed

50.

Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002) Tumour ‘budding’ as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40:127–132PubMedCrossRef

51.

Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R et al (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261–268PubMedCrossRef

52.

van Wyk Q, Hosie KB, Balsitis M (2000) Histopathological detection of lymph node metastases from colorectal carcinoma. J Clin Pathol 53:685–687PubMedCrossRef

53.

Verrill C, Carr NJ, Wilkinson-Smith E, Seel EH (2004) Histopathological assessment of lymph nodes in colorectal carcinoma: does triple levelling detect significantly more metastases? J Clin Pathol 57:1165–1167PubMedCrossRef

54.

Wheeler JMD, Warren BF, Jones AC, Mortensen NJM (1999) Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br J Surg 86:1108–1120PubMedCrossRef

55.

Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM Supplement. A commentary on uniform use. Wiley-Liss, New York

56.

Wright FC, Law CHL, Last L, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S, Smith AJ (2003) Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol 10:903–909PubMedCrossRef

Titel: Recommendations for the reporting of surgically resected specimens of colorectal carcinoma
verfasst von: Jeremy R. Jass
Michael J. O’Brien
Robert H. Riddell
Dale C. Snover
Publikationsdatum: 01.01.2007
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 1/2007
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-006-0302-6

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Recommendations for the reporting of surgically resected specimens of colorectal carcinoma

Excerpt

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

High-risk human papillomavirus type 16 E7 oncogene associates with Cdc25A over-expression in oral squamous cell carcinoma

Synovial tumefactive extramedullary hematopoiesis associated to polycythemia vera

Small hepatic vein involvement in IgG multiple myeloma: a very unusual pattern of liver infiltration

CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression

Cotyledonoid dissecting leiomyoma of the uterus with intravascular growth: report of two cases

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie